Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors: Radiant Insights
A number of common etiologic factors have been strongly characterized as raising the risk of developing cancer, including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. The risk of cancer increases greatly in patients over the age of 65. Populations in developed countries are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and revenue growth for its treatments.
There has been a shift towards developing targeted therapies, such as mAbs and cell therapies. Targeted therapies, by their nature, have less toxicity associated with their use and as a result can be administered to more cancer patients, who are commonly elderly and have co-morbidities, therefore increasing the overall survival of this group and the number of treatment cycles they may receive. The most commercially successful oncology treatments are mAbs such as MabThera/Rituxan, Avastin and Herceptin.
Download Full Research Report of Global Oncology Market to 2023 @ https://www.radiantinsights.com/research/global-oncology-market-to-2023
- Global revenue for the oncology market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 10.66%, from $118.6 billion in 2016 to $241.0 billion in 2023. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
- The oncology pipeline is large and fairly diverse and contains 7,773 products. How does the composition of the pipeline compare with that of the existing market? What are the most popular types of molecule type and molecular target in the pipeline?
- What mechanisms of action and molecule types are most common for pipeline products being trialed in the various key indications?
- How will the market shares and CAGRs of the top 20 pharma companies compare within oncology?
- What proportion of the key players’ revenues will be attributable to oncology products?
Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-oncology-market-to-2023/request-sample
Reasons to buy
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis
- Visualize the composition of the oncology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
- Analyze the oncology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
- Understand the growth in patient epidemiology and market revenue for the oncology market globally and across the key players and product types
- Stratify the market in terms of the generic and premium product revenue split between oncology products and assess the role of these product types in the treatment of the various cancers
- Identify commercial opportunities in the oncology deals landscape by analyzing trends in licensing and co-development deals
Read more related reports by Radiant Insights:
• Orally Disintegrating Tablet Sales Market- https://www.radiantinsights.com/research/global-orally-disintegrating-tablet-sales-market-report-2017
• Haemocoagulase Agkistrodon for Injection Market- https://www.radiantinsights.com/research/global-haemocoagulase-agkistrodon-for-injection-market-professional-survey-report-2017
Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 10
2.1 Therapy Area Introduction 10
2.2 Symptoms 11
2.3 Diagnosis 12
2.4 Etiology and Pathophysiology 13
2.4.1 Etiology 13
2.4.2 Pathophysiology 15
2.5 Co-morbidities and Complications 16
2.6 Epidemiology Patterns - Prevalence, Patient Segmentation, and Diagnostic and Treatment Usage Rates 17
2.6.1 Breast Cancer 17
2.6.2 Colorectal Cancer 18
2.6.3 Lung Cancer 19
2.6.4 Prostate Cancer 20
2.6.5 Hematological Cancers 21
2.7 Prognosis 22
2.7.1 Breast Cancer 22
2.7.2 Colorectal Cancer 23
2.7.3 Non-Small-Cell Lung Cancer 23
2.7.4 Prostate Cancer 24
2.8 Treatment 25
2.8.1 Surgery and Radiation Therapy 25
2.8.2 Chemotherapy 26
2.8.3 Hormonal Therapies 28
2.8.4 Targeted Therapies 29
About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience help for delivering excellence in all research projects.
201 Spear Street 1100,
CA 94105, United States
Toll Free: 1-888-928-9744
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors: Radiant Insights here
News-ID: 742813 • Views: 435
More Releases from Radiant Insights, Inc.
Global Vascular Graft Market Outlook and Forecast 2018-2023
The report segments the market and forecasts its size, by volume and value, on the basis of product, by application, and by geography (North America, Europe, Asia-Pacific, MEA and South America). Download Free Sample Report @ http://bit.ly/2Jrt8uK The report covers forecast and analysis for the vascular graft market on a global and regional level. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both
Dried Fruits Market is Expected to Gain a Positive CAGR Growth By 2018
Dried Fruits Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Dried Fruits basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures,
Cobalt Sulfate Market Outlook and Industry Overview 2018-2022
Cobalt sulphate is an inorganic chemical that is available in the form of a reddish, metallic salt. It is toxic and soluble in water and other organic solvents. It is produced when cobalt metal or its salts react with aqueous sulphuric acid. It is primarily used as an electrode in batteries. Radiant Insights, Inc's analysts forecast the Global Cobalt Sulfate Market to grow at a CAGR of 13.9% during the
Well Logging Equipment Market Sales, Growth, Sales, Growth, Analysis and Forecas …
This report studies the global Well Logging Equipment market status and forecast, categorizes the global Well Logging Equipment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The global Well Logging Equipment market is valued at million US$ in 2017 and
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and